Table 4.

Percentage of Adult Survivors of Childhood Cancer Treated With Therapies Associated With Increased Risk for Late Effects Reporting an Absence of the Following Types of Outpatient Medical Care in a 2-Year Period, Compared With All Survivors

		Absence of
		General Medical Contact			General Physical Examination			Cancer-Related Medical Visit			Cancer Center Medical Visit
Variable	Total No.	%	OR	(95% CI)	%	OR	(95% CI)	%	OR	(95% CI)	%	OR	(95% CI)
Note: results adjusted for age, sex, and race; percentages are based upon the total with available data for each variable.
OR = odds ratio; CI = confidence intervals; RT = radiation therapy.
* High-risk therapy: treatment with any of the following: chest-mantle radiation, anthracycline >300 mg/m², bleomycin, etoposide, or ifosfamide.
Chest-mantle RT
No	6,013	12.5	1.00	Referent	30.6	1.00	Referent	59.4	1.00	Referent	79.7	1.00	Referent
Yes	1,802	8.2	0.68	0.57–0.83	24.6	0.64	0.56–0.73	47.9	0.60	0.53–0.67	70.3	0.50	0.43–0.57
Anthracycline
<300 mg/m²	6,459	11.1	1.00	Referent	29.4	1.00	Referent	53.6	1.00	Referent	72.6	1.00	Referent
≥300 mg/m²	1,508	10.7	0.88	0.73–1.06z	27.4	0.96	0.84–1.11	51.7	0.77	0.68–0.88	69.8	0.65	0.56–0.75
Bleomycin
No	7,642	12.2	1.00	Referent	29.4	1.00	Referent	58.4	1.00	Referent	81.5	1.00	Referent
Yes	581	7.8	0.58	0.42–0.81	25.7	0.80	0.65–0.99	40.8	0.48	0.40–0.58	67.0	0.47	0.38–0.57
High-risk therapy*
No	4,304	13.2	1.00	Referent	31.3	1.00	Referent	61.9	1.00	Referent	83.1	1.00	Referent
Yes	3,449	10.0	0.70	0.60–0.82	26.4	0.74	0.66–0.83	50.7	0.58	0.53–0.65	71.1	0.45	0.39–0.50